Quanterix Q1 Revenues Fall 4 Percent as Instrument Sales Decline
Product and service and other revenues were both down year over year, while collaboration and grant revenues rose.
Firms including Roche and Quest have moved into the space, providing both a vote of confidence and new competition for smaller players that pioneered it.
Quanterix Q4 Revenues Down 15 Percent
The company posted revenues of $25.8 million for the quarter, down from $30.3 million in Q4 2021 and in line with the consensus Wall Street estimate.
Drug Approvals Spark Interest in Alzheimer's Plasma Markers; Utility, Applications Still Uncertain
Blood-based tests offer less invasive and less costly tools for diagnosing and monitoring Alzheimer's, but the field is still establishing which will be most informative.
Quanterix Restructuring Efforts on Track, CEO Says at JP Morgan Conference
The restructuring is to scale its operations and assays to better meet both current and anticipated demand for higher-throughput testing, its CEO said.